Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01374074 · ClinicalTrials.gov registry record
Racial Disparity in Barrett's Esophagus
A clinical trial of Barrett's Esophagus and Gastroesophageal Reflux Disease (GERD), sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 255
- Enrollment target
- 1
- Study location
NCT01374074 is a study of Barrett's Esophagus and Gastroesophageal Reflux Disease (GERD) that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 255 participants, below the 513-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01374074, a study of Barrett's Esophagus and Gastroesophageal Reflux Disease (GERD), has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 255 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of the proposed research is to investigate the molecular mechanisms of racial disparity in Barrett's esophagus (BE), the premalignant lesion of esophageal adenocarcinoma. Specifically, the investigators hypothesize that environmental factors, genetic factors, and potentially gene environment interactions play crucial roles in the observed racial disparity in developing Barrett's esophagus. Patients are recruited through UNC hospitals prior to scheduled esophagogastroduodenoscopy (EGD). Participants complete a questionnaire, have body measurements obtained, and have blood, biopsies, and gastric aspirate collected. Participants also complete a 24 hour pH impedance test.
Conditions Studied
Study Locations (1)
North Carolina
- University of North Carolina Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2011-03 |
| Est. Completion | 2014-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01374074
The ClinicalTrials.gov registry entry for NCT01374074 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 255 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 513-participant average among 22 other Barrett's Esophagus trials with a reported enrollment target (50% lower). The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Barrett's Esophagus appearing as the primary indexed condition, and to 0 interventions.
NCT01374074 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT01374074 about?
NCT01374074 is a clinical study titled "Racial Disparity in Barrett's Esophagus". The goal of the proposed research is to investigate the molecular mechanisms of racial disparity in Barrett's esophagus (BE), the premalignant lesion of esophageal adenocarcinoma. Specifically, the investigators hypothesize that environmental factors, genetic factors, and potentially gene environmen...
What is the current status of trial NCT01374074?
This trial is currently completed. The enrollment target is 255 participants. The study started on 2011-03. Estimated completion is 2014-01.
What conditions does trial NCT01374074 study?
This clinical trial studies the following conditions: Barrett's Esophagus, Gastroesophageal Reflux Disease (GERD), Intestinal Metaplasia.
Who is sponsoring clinical trial NCT01374074?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01374074 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett's Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pilot Study for TCE Imaging of the Esophagus Using an OFDI Capsule With a Compact Imaging System
RECRUITING · NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
RECRUITING
-
Barrett's Esophagus Related Neoplasia (BERN) Project
RECRUITING
-
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING
-
TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
RECRUITING
-
Navicam for Detection of Barrett's Esophagus
RECRUITING · NA
Explore more on PlainTrial
Barrett's Esophagus
All registered trials for this condition
Gastroesophageal Reflux Disease (GERD)
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.